Erratum: The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double-blind placebo-controlled and randomized study (BJU International (2010) 106:6 (840-7) doi: 10.1111/j.1464-410X.2009.09154.x);The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: A double-blind placebo-controlled and randomized study

BJU International

Volumn 106, Issue 6, 2010, Pages 840-847

  Safarinejad, Mohammad Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

bupropion; male; sexual dysfunction; SSRI; treatment

Indexed keywords

AMFEBUTAMONE; CITALOPRAM; FLUOXETINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; DOPAMINE UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MALE SEXUAL DYSFUNCTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUAL FUNCTION; SUSTAINED RELEASE FORMULATION; TREATMENT DURATION; CHEMICALLY INDUCED; COMPLICATION; DEPRESSIVE DISORDER, MAJOR; DRUG EFFECTS; EPIDEMIOLOGY; MIDDLE AGED; PATIENT SATISFACTION; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TREATMENT OUTCOME;

ADULT; BUPROPION; DEPRESSIVE DISORDER, MAJOR; DOPAMINE UPTAKE INHIBITORS; EPIDEMIOLOGIC METHODS; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; SEROTONIN UPTAKE INHIBITORS; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TREATMENT OUTCOME;

EID: 77956210091     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.13064     Document Type: Erratum

References (39)

1. Williams VSL, Baldwin DS, Hogue S et al. Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in two European countries: a cross-sectional patient survey. J Clin Psychiatry 2006 67 : 204 210
2. Balon R. SSRI-associated sexual dysfunction. Am J Psychiatry 2006 163 : 1504 1509
3. Safarinejad MR. Prevalence and risk factors for erectile dysfunction in a population-based study in Iran. Int J Impot Res 2003 15 : 246 252
4. Montgomery SA, Baldwin DS, Riley A. Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction. J Affect Disord 2002 69 : 119 140
5. National Ambulatory Care Medical Survey. 1997 summary. Adv Data 1999 305 : 1 28
6. Lane RM. A critical review of selective serotonin reuptake inhibitor-related sexual dysfunction: incidence, possible aetiology and implications for management. J Psychopharmacol 1997 11 : 72 82
7. Nurnberg HG. An evidence-based review updating the various treatment and management approaches to serotonin reuptake inhibitor-associated sexual dysfunction. Drugs Today (Barc) 2008 44 : 147 168
8. Meston CM. A randomized, placebo-controlled, crossover study of ephedrine for SSRI-induced female sexual dysfunction. J Sex Marital Ther 2004 30 : 57 68
9. Safarinejad MR. Evaluation of endocrine profile and hypothalamic- pituitary-testis axis in selective serotonin reuptake inhibitor-induced male sexual dysfunction. J Clin Psychopharmacol 2008 28 : 418 423
10. Masand PS, Ashton AK, Gupta S et al. Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study. Am J Psychiatry 2001 158 : 805 807
11. Nurnberg HG, Hensley PL, Gelenberg AJ et al. Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial. JAMA 2003 289 : 56 64
12. Segraves RT, Lee J, Stevenson R et al. Tadalafil for treatment of erectile dysfunction in men on antidepressants. J Clin Psychopharmacol 2007 27 : 62 6
13. Safarinejad MR, Hosseini SY. Salvage of sildenafil failures with bremelanotide: a randomized, double-blind, placebo controlled study. J Urol 2008 179 : 1066 1071
14. Atkinson JH, Slater MA, Wahlgren DR et al. Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity. Pain 1999 83 : 137 145
15. Wilens TE, Haight BR, Horrigan JP et al. Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study. Biol Psychiatry 2005 57 : 793 801
16. Segraves RT, Clayton A, Croft H et al. Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. J Clin Psychopharmacol 2004 24 : 339 342
17. Clayton AH. Female sexual dysfunction related to depression and antidepressant medications. Curr Womens Health Rep 2002 2 : 182 187
18. Stahl SM, Pradko JF, Haight BR et al. A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Prim Care Companion J Clin Psychiatry 2004 6 : 159 166
19. Clayton AH, Warnock JK, Kornstein SG et al. A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry 2004 65 : 62 7
20. DeBattista C, Solvason B, Poirier J et al. A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction. J Clin Psychiatry 2005 66 : 844 848
21. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960 23 : 56 62
22. Frank E, Prien RF, Jarrett RB et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991 48 : 851 855
23. Rosen R, Riley A, Wagner G et al. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997 49 : 822 830
24. Guy W. ECDEU Assessment Manual for Psychopharmacology. Washington : National Institute of Mental Health, US Department of Health, Education, and Welfare, 1976
25. McGahuey CA, Gelenberg AJ, Laukes CA et al. The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther 2000 26 : 25 40
26. Althof SE, Corty EW, Levine SB et al. EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology 1999 53 : 793 799
27. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959 32 : 50 5
28. Murray JB. Physiological mechanisms of sexual dysfunction side effects associated with antidepressant medication. J Psychol 1998 132 : 407 416
29. Aukst-Margetić, B, Margeti B. An open-label series using loratadine for the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 754-6
30. Ramasubbu R. Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression. J Psychiatry Neurosci 1999 24 : 45 50
31. Herrera-Guzmán I, Gudayol-Ferré E, Lira-Mandujano J et al. Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder. Psychiatry Res 2008 160 : 72 82
32. Paredes RG, Agmo A. Has dopamine a physiological role in the control of sexual behavior? A critical review of the evidence. Prog Neurobiol 2004 73 : 179 226
33. Viitamaa T, Haapalinna A, Agmo A. The adrenergic alpha2 receptor and sexual incentive motivation in male rats. Pharmacol Biochem Behav 2006 83 : 360 369
34. Montejo-González AL, Llorca G, Izquierdo JA et al. SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther 1997 23 : 176 187
35. Clayton A, Keller A, McGarvey EL. Burden of phase-specific sexual dysfunction with SSRIs. J Affect Disord 2006 91 : 27 32
36. Landén M, Eriksson E, Agren H et al. Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol 1999 19 : 268 271
37. Jespersen S, Berk M, Van Wyk C et al. A pilot randomized, double-blind, placebo-controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use. Int Clin Psychopharmacol 2004 19 : 161 164
38. Michelson D, Bancroft J, Targum S et al. Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention. Am J Psychiatry 2000 157 : 239 243
39. Balon R, Yeragani VK, Pohl R et al. Sexual dysfunction during antidepressant treatment. J Clin Psychiatry 1993 554 : 209 212